Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
19 studies found for:    "Minimal change disease"
Show Display Options
Rank Status Study
1 Recruiting Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease
Condition: Minimal Change Disease
Interventions: Drug: tacrolimus;   Drug: prednisolone
2 Completed Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome
Condition: Minimal Change Disease
Intervention: Drug: Tacrolimus
3 Active, not recruiting A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome
Conditions: MCNS;   Minimal Change Nephrotic Syndrome (MCNS)
Interventions: Drug: Tacrolimus;   Drug: Prednisolone
4 Completed The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy
Condition: IgA Nephropathy
Intervention: Drug: Prednisone or Prednisolone
5 Completed Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS)
Condition: Nephrotic Syndrome
Intervention: Drug: Rituximab
6 Recruiting Myfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized Study
Condition: Nephrosis, Lipoid
Interventions: Drug: Myfortic plus low-dose steroid;   Drug: Prednisolone
7 Recruiting Nephrotic Syndrome Study Network
Conditions: Minimal Change Disease (MCD);   Membranous Nephropathy;   Glomerulosclerosis, Focal Segmental
Intervention: Procedure: Kidney Biopsy
8 Not yet recruiting Valproic Acid for Idiopathic Nephrotic Syndrome
Conditions: Idiopathic Nephrotic Syndrome;   Focal Segmental Glomerulosclerosis;   Minimal Change Disease
Intervention: Drug: Valproic Acid
9 Completed Retinoids for Minimal Change Disease and Focal Segmental Glomerulosclerosis
Conditions: Collapsing Glomerulopathy;   Glomerulosclerosis, Focal Segmental
Interventions: Procedure: Kidney needle biopsy;   Procedure: DEXA Scan;   Procedure: X-rays;   Drug: Retinoids for Podocyte Disease
10 Recruiting Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)
Condition: Nephrotic Syndrome
Interventions: Drug: Abatacept;   Other: Normal Saline;   Other: D5W
11 Completed Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic Syndrome
Condition: Nephrotic Syndrome
Intervention: Drug: acid mycophenolic (Myfortic)
12 Completed MRCP: A Reliable, Non Invasive Method for Staging Chronic Pancreatitis in Pediatrics
Condition: Healthy Volunteers
Intervention: Drug: Secretin
13 Completed Efficacy of Rituximab For the Treatment of Calcineurin Inhibitors Dependent Nephrotic Syndrome During Childhood
Condition: Childhood Idiopathic Nephrotic Syndrome
Interventions: Drug: Rituximab;   Drug: Placebo
14 Recruiting INSIGHT (Insight Into Nephrotic Syndrome)
Condition: Nephrotic Syndrome
15 Completed Kidney Disease Biomarkers
Conditions: Kidney Disease;   Glomerular Disease;   Idiopathic Nephrotic Syndrome;   Focal Segmental Glomerulosclerosis;   Collapsing Glomerulopathy
16 Recruiting Vitamin D Supplementation in Glomerular Disease
Condition: Glomerular Disease
Intervention: Dietary Supplement: Cholecalciferol, 2000 or 4000 IUs by mouth daily for 12 weeks
17 Completed
Has Results
Steroid Treatment for Kidney Disease
Conditions: Nephrosis;   Focal Lipoid Glomerulosclerosis
Intervention: Drug: Oral dexamethasone
18 Recruiting Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure
Conditions: Focal Segmental Glomerulosclerosis;   Nephrotic Syndrome;   End Stage Renal Disease;   Kidney Failure;   Unexplained Proteinuria
19 Completed
Has Results
Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)
Condition: Treatment Resistant Nephrotic Syndrome
Intervention: Drug: ACTHAR gel

Study has passed its completion date and status has not been verified in more than two years.